Gynecologic Cancer, Remission
Conditions
Keywords
supportive oncology care, personalized post-cancer plan
Brief summary
This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.
Interventions
Delivery of a personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital
OTHERStandard assesment
Delivery of a personalized post-cancer plan without a day hospital
OTHERObservational cohort
Patients with no cancer sequelae, no adverse effects and no need for oncological support care will not be randomized, but will be followed as part of an observational cohort
Sponsors
Centre Francois Baclesse
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient \> 18 years * Patients in remission from first-line treatment of endometrial or ovarian/tumor/peritoneal cancer. * Patient who has completed her initial treatment; patients on maintenance therapy are eligible. * Fluency in French * Patient with access to a telephone line * Patient affiliated to a social security scheme * Signature of informed consent prior to any specific study procedure
Exclusion criteria
* Any associated medical or psychiatric condition that could compromise the patient's ability to participate in the study * Patient with locoregional or metastatic recurrence * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Compare the proportion of patients for whom the supportive oncology care recommended in the personalized post-cancer plan has been implemented. | 6 months after delivery of personalized post-cancer plan, i.e. about 8 months after inclusion | The primary criterion is the proportion of patients who have implemented at least one of the supportive oncology treatments recommended in the personalized post-cancer plan within 6 months of receiving the personalized post-cancer plan. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Comparison, 12 months after delivery of the personalized post-cancer plan, of the impact of the intervention on the improvement of side effects and/or sequelae identified at the end of the initial treatments. | 12 months after delivery of personalized post-cancer plan, i.e. about 14 months after inclusion | Proportion of patients presenting, at 12 months, an improvement (reduction in grade according to CTCAE v5.0 criteria) in at least one of the side effects and/or sequelae identified at the end of the initial treatments according to the INCa identification grids (1st and 2nd levels). |
Countries
France
Contacts
Primary ContactFlorence JOLY, Prof
Outcome results
None listed